Literature DB >> 23121869

Lifting the mood on treating fragile X.

Emily K Osterweil1, Peter C Kind, Mark F Bear.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23121869     DOI: 10.1016/j.biopsych.2012.09.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  4 in total

1.  Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.

Authors:  Dalyir I Pretto; Madhur Kumar; Zhengyu Cao; Christopher L Cunningham; Blythe Durbin-Johnson; Lihong Qi; Robert Berman; Stephen C Noctor; Randi J Hagerman; Isaac N Pessah; Flora Tassone
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

2.  Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome.

Authors:  Lara Costa; Lara M Sardone; Enza Lacivita; Marcello Leopoldo; Lucia Ciranna
Journal:  Front Behav Neurosci       Date:  2015-03-12       Impact factor: 3.558

Review 3.  Increasing our understanding of human cognition through the study of Fragile X Syndrome.

Authors:  Denise Cook; Erin Nuro; Keith K Murai
Journal:  Dev Neurobiol       Date:  2013-07-30       Impact factor: 3.964

4.  FMRP regulates an ethanol-dependent shift in GABABR function and expression with rapid antidepressant properties.

Authors:  Sarah A Wolfe; Emily R Workman; Chelcie F Heaney; Farr Niere; Sanjeev Namjoshi; Luisa P Cacheaux; Sean P Farris; Michael R Drew; Boris V Zemelman; R Adron Harris; Kimberly F Raab-Graham
Journal:  Nat Commun       Date:  2016-09-26       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.